tiprankstipranks

Jennifer Lew Insider Profile

11 Followers
Jennifer Lew, CFO at Chinook Therapeutics, holds 86.47K shares in Annexon Biosciences (Ticker: ANNX), holds 135.16K shares in Chinook Therapeutics (Ticker: KDNY), holds 2.33K shares in Dynavax (Ticker: DVAX).
tipranks
Jennifer Lew

Jennifer Lew
Chinook Therapeutics (KDNY)
CFO

Ranked #18,694 out of 99,797 Corporate Insiders

Profitable Transactions

60%
6 out of 10 Profitable Transactions

Average Return

+8.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$482K
93.84%
6.16%
A breakdown of Jennifer Lew's holdings

Insider Roles

Annexon Biosciences
(ANNX)
EVP & CFO
Dynavax
(DVAX)
VP, Finance & PAO
Roles that Jennifer Lew holds in companies

Most Profitable Insider Trade

Stock:
Chinook Therapeutics
(KDNY)
Rating:Informative Sell
Date:Sep 14, 2018 - Sep 14, 2019
Return:+80.80%
The most profitable trade made by Jennifer Lew

Jennifer Lew's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
KDNY
Chinook Therapeutics
Dec 14, 2018
Informative Sell
3.03K
$5.46M
Annexon Biosciences
Jul 17, 2024
EVP & CFO
Uninformative Sell
6.66K
$452.23K
Dynavax
Sep 14, 2012
VP, Finance & PAO
Informative Sell
84.94K
$29.66K
List of latest transactions for each holding click on a transaction to see Jennifer Lew's performance on stock

Jennifer Lew insider profile FAQ

What is the percentage of profitable transactions made by Jennifer Lew?
The percentage of profitable transactions made by Jennifer Lew is 60%.
    What is the average return per transaction made by Jennifer Lew?
    The average return per transaction made by Jennifer Lew is 8.00%.
      What stocks does Jennifer Lew hold?
      Jennifer Lew holds: KDNY, ANNX, DVAX stocks.
        What was Jennifer Lew’s latest transaction?
        Jennifer Lew latest transaction was an Uninformative Sell of $6.66K.
          What was Jennifer Lew's most profitable transaction?
          Jennifer Lew’s most profitable transaction was an Informative Sell of KDNY stock on September 14, 2018. The return on the trade was 80.80%.
            What is Jennifer Lew's role in Chinook Therapeutics?
            Jennifer Lew's role in Chinook Therapeutics is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.